3_primer_mankad_hoey_20150316195806 Flashcards
Hepatic Artery Variants
50-60% from CHA via Coeliac axis, then CHA divides to proper HA and GDA10% CHA divides into RHA and GDA10% CHA divides into LHA and GDANormal HA velocity 30-60 cm/s; RI 0.6±0.06; continuous diastolic flow
Portal Vein
Hepatopetal, non-pulsatile, mild respiratory variationFlow velocity 20-30 cm/sDiameter 12-14 mm
Hepatic Vein
Triphasic with respiratory and cardiac variationHV sampling occurs at its confluence
Cirrhotic nodules
Regenerative (hepatocytes and stroma; not seen on US unless large; on CT are high attenuation if siderotic)Cirrhotic (regenerative nodules with surrounding fibrosis)Dysplastic (hepatic adenomas with areas of dysplasia; due to HBV and HCV)
Imaging features of Cirrhosis
Decrease size of right lobe and medial left lobe, with caudate lobe hypertrophyMRI:Regenerative nodules: high T1W, low T2W;Dysplastic: high T1W, very low T2W, with post Gd enhancement;Neoplastic: arterial enhancement with PV washout; nodule-in-nodule on T2W (high T2W neoplastic within low T2W dysplastic nodule)
Haemochromatosis
Primary (AR) due to increased uptake of transferrinSecondary - erythrogenic, Bantu siderosis or transfusional (>30 units blood)CT - high attenuation liver with low attenuation PV branchesMR - Liver low T1W and T2W relative to muscle, with susceptibility on GRE; pancreas low late in disease, spleen normal in primary but low in secondary disease
Liver Abscess
Cause: 80-90% bacterial, 5% amoebic, 50%), ofetn contain gas and 60-70 y/o peakAmoebic: due to entamoeba histolytica, usually 30-50 y/o, usually single, in peripheral right lobe and often >5 cmImaging: raised right hemidiaphragm, hypoechoic initally, then developing thick reflective wallCT signs specific to pyogenic abscess: Double target sign (enhancing wall with surrounding oedema), cluster sign (clustered abcesses)MR: Low T2W, high T2W, enhancing wall, low signal wall on T2W with surrounding perilesional oedemaNM: Uptake of sulphur colloid; Gallium taken up by pyogenic but not amoebic
Hepatic Haemangioma
Commonest benign liver lesion (70 to 80%), usually 4 cm = giant cavernous haemangioma.Associations: FNH, HHT, Kasabach-Merritt Syndrome (Haemangioma and thrombocytopaenia).Supplied from hepatic artery, may rupture spontaneously.Usually hyperechoic on US, ± posterior acoustic enhancement, no flow on DopplerCT: low attenuation with early peripheral nodular enhancement, delayed centripetal fill in to maximal at 15 minutes.MR: Sharply defined, low T1W, very high T2W, central fibrous scar, similar enhancement to CT.
FNH
Second commonest benign liver lesion, usually right lobe, FCentral scar (containing AVM), usually on liver surface, non-encapsulated ± pedunculated,, very vascular, contains Kupffer cells, non-calcifiedUS: Homogeneously hyperechoic with hypoechoic central scar in 15-20%, displaces vessels around it, enlarged central artery and peripheral draining veins visible on DopplerCT: Ill-defined, transiently high attenuation in PV phase with gradual equilibration, central scar on delayed, ‘spoke-wheel’ pattern in 20-30%MR: Isointense on T1W and T2W, central scar hypointense on T1W and hyperintense (in 75%) on T2W; initial Gd avid enhancement with gradual equilibration (early enhancement of central scar); SPIOd (Kupffer specific) cause lesion enhancement
Hepatocellular adenoma
Women on COCP and men on anabolic steroids, 20-40 y/o, usually 5-10 cm, subcapsular in right lobeContain mixture of hepatocytes, Kupffer cells and fat, but no portal tracts; usually contains haemorrhage and necrosisUS: Heterogeneous, solid, with hypoechoic rimCT: well defined, ±hyperdense if areas of haemorrhageMR: can’t be distinguished from HCC, predominantly hyperintense T1W and isointense T2WNM: Photopaenic on sulphur colloid, no uptake on Gallium
HCC
Commonest visceral malignancy, peak 60-70 y/o;Solitary (30%), Multifocal (60-70%) and diffuse (5%) forms; invades PV in 50-60% and IVC in in siderotic noduleLarge HCC: Mosiac pattern (confluent nodules, small septae, best seen on T2W), tumour capsule (hypointense) in 60-80%, extracapsular extension with satellite nodules in 50-70%, tumour thrombus as high T1W and T1 GRE in PV, with arterial enhancementNM: photopaenic on sulphur colloid, avid uptake on Gallium
Fibrolamellar HCC
No RFs for HCC, 30-40 y/oSolitary lobulated lesion, central scar, pseudocapsule of hepatic tissue, central amorphous calcification in 30-40%Regional LNs 50-60%, rarely metastasises, no vascular invasionUS: Heterogeneous with hyperechoic central scarCT: Lobulated enhancing mass with non-enhancing central scarMR: Hypointense T1W, hyperintense T2W with heterogenous enhancement; scar hypointense on T1W and T2W and non-enhancing
Liver metastases
Usually colon, breast, lung or pancreas; solitary in 10%, both lobes in 75%US: variable, echogenic usually GIT or GU; no Doppler flow except with carcinoidExclusion criteria for metastatectomy - advanced primary, >4 metastases, extrahepatic metastases, <30% liver remaining post surgeryCalcified liver metastases: gastric, melanoma, RCC, colon, ovarianHypervascular metastases: thyroid, renal, carcinoid, melanoma, pancreatic islet cellHaemorrhagic metastases: Colon, thyroid, breast, choriocarcinoma, melanoma
Budd Chiari Syndrome
Hepatic vein of IVC obstruction, 60-70% idiopathicCauses of thrombotic obstruction (5 P’s): Pregnancy, Pill, Polycythaemia Rubra Vera, abnormal Platelets, PNHNon-thrombotic obstruction: Right heart failure, constrictive pericarditis, right atrial tumour, IVC membraneUS: Hepatosplenomegaly, ascites, caudate lobe hypertrophy, ascites, prominent portosystemic anastomoses and azygos/hemiazygos systems, absent / reversed flow in hepatic veins, hepatic arterial resistance index >0.7CT: Heterogenous liver enhancement, caudate large and normally enhancing, poor opacification of hepatic veins
Hepatic veno-occlusive disease
Post radiation / chemotherapyMR: occlusion of centrilobular venules without major hepatic vein thrombosisUS: Bidirectional flow in portal veins without hepatic vein / IVC obstruction, GB wall thickening
Portal vein thrombosis
Causes: idiopathic (neonates), malignancy (in 30% of HCC, also cholangioCa, pancreatic Ca, liver metastases), hypercoaguable, trauma (iatrogenic - umbilical vein catheter), peritonitis, pancreatitis, ascending cholangitisUS: Echogenic material on PV, increased PV diameter, thickened lesser omentum
Peliosis hepatis
Rare benign dilatation of sinusoidal blood filled spaces in reticuloendothelial system (liver, spleen, marrow, lymph nodes, lungs)Causes: AIDS, TB, Anabolic steroids, CRF, tamoxifenUS: Multiple hyper-/hypoechoic areasCT: Enhancing, round lesions in organs; initially low attenuation then isoattenuating with time
Biliary anatomy
RPHD into LHD 20%RPHD, RAHD, LHD trifluence 10%75% cystic duct inserts into middle third of extrahepatic CHD, 10% distal CHDCBD / PD / Ampulla - 75% Y, 25% V, 5% UCHD measured at level of HA, normal <7 mmSecretin transiently distends pancreatic duct (maximal at 2 minutes post injection) prior to MRCP
Choledochal cysts
Cystic dilatations of CBD; 30-40% present at <1 y/o.Clinical features: Intermittent obstructive jaundice, RUQ pain and RUQ mass (25% triad)Associations: Biliary, pancreatic anomalies and liver cysts
Caroli’s disease
Segmental dilatation of intrahepatic bile ducts, autosomal recessive, causes biliary stasis with intrahepatic calculi then secondary pyogenic cholangitis, intrahepatic abscesses, increased risk cholangiocarcinomaAssociations: Medullary sponge kidney (80%), Infantile polycystic kidney disease’Central dot sign’ - specific, portal radicals surrounded by abnormally dilated / ectatic bile ducts
Chemotherapy cholangitis
Most commonly associated with floxuridine; strictures of CHD and bifurcation, sparing of distal CBD
Cholelithiasis
Cholesterol (70-80%) but 70% mixed, 20% radiopaque, associated with cirrhosisPigment (30%) 2-5 mm, faceted, calcium bilirubinate, 50% radiopaqueWall-echo-shadow complex (double arc sign) when GB contracted over GS (but also seen with porcelain GB and emphysematous cholecystitis)Sludge (echogenic bile) - 100% fasting patients at 6 weeks (decreased CCK)
Biliary Enteric fistulae
Most commonly biliary-duodenal (70%; can cause GS ileus)Causes: Chronic cholecystitis with GS erosion into GIT (90%), Penetration of posterior DU into CHD (5%)
Bouveret syndrome
Obstruction of stomach or duodenum by GS
Mirizzi syndrome
Obstruction of CHD by stone in cystic duct; causes cholecystitis
Complications of Acute cholecystitis
Usually GB wall > 3 mm, lumen distended > 4 cmMurphy’s sign 60% sensitive, 90% specific95% calculous, 5% acalculous (GB dysmotility with bacterial superinfection)Gangrenous cholecystitis (rupture), 20% mortality but neural death causes 60% Murphy’s negativeEmphysematous cholecystitis (ischaemia due to inflammation / vasculitis, rare; pneumobilia and air around GB on PFA; 40% diabetic)EmpyemaGS ileus
Xanthogranulomatous cholecystitis
Thickened GB wall with intramural nodules; can mimic adenoCaUsually 70-80 y/o femaleComplications (30%) - perforation, abscess, fistulae
Porcelain GB
Usually due to chronic cholecystitis (GB doesn’t react to CCK)Increased risk GB Carcinoma (15% lifetime risk)
GB US in AIDS
Hepatosplenomegaly (30%), ascites (15%), lymphadenopathy (20%)GB wall thickening (7%; may be due to acalculous cholecystitis due to cryptosporidium, CMV)GS (6%)
Cholangitis
Infection of obstructed bile ducts E coli > klebsiella > pseudomonas; 80-90% supparative60% due to GS or post surgical strictures, but can be due to ampullary tumour
PSC
Chronic obliterative fibrosis of biliary tree, usually mostly intrahepatic, always involves CBDString of beads on cholangiogram, pruning of biliary tree10% risk cholangiocarcinoma; can also cause biliary cirrhosis.Associations: IBD, pancreatitis, Sjogrens, RPF, Peyronie’s
Strawberry GB
Deposition of triglycerides and macrophages in GB wall, studded ‘strawberry’ appearance of wall (<1 mm echogenic lipid deposits, multiple 0.5 mm polyps)
GB adenomyomatosis
Hyperplasia GB wall, enlarged Rokitansky-Aschoff sinuses, hypercontractile wall
GB adenomas
10% multiple, F>M, usually 5-20 mm, 60% associated with GSAssociated with Peutz Jeghers, FAP
Cholangiocarcinoma
Usually at hilum or distal CBD (30-40%)Associations: GS (90%), PSC, Caroli’s disease, Biliary atresia, IBD (UC > Crohns), Porcelain GB (15% risk), familial polyposis, adult polycystic kidney disease, clonarchis (asians), toluene exposureIntrahepatic: Mass with satellite nodules, dilated biliary tree with hyperechoic mass; Klatskin tumour - at confluence of RHD and LHD (causing segmental dilatation of main ducts, PV obstruction and lobar atrophy)Extrahepatic: 10% present with cholangitis, pure intrahepatic biliary dilatation
GB Adenocarcinoma spread
Direct invasion of liver (50%), liver metastases (5%)Direct invasion of duodenum (50%)Carcinomatosis (50%)
Von Meyenburg Complex
Bile duct hamartoma, usually 1-5 mm, composed of disorganised bile ducts and fibrocollagenous stroma
Pancreas Divisum
Lack of fusion of dorsal and ventral pancreatic ducts, 10% of population.Main pancreatic drainage is through the minor papilla (too small to handle secretions).25% of patients with recurrent idiopathic pancreatitis have pancreas divisum.
Annular Pancreas
Abnormal migration of the ventral pancreas, surrounds and obstructs second portion of duodenumERCP: pancreatic duct encircles the duodenum. Increased incidence of pancreatitis and peptic ulcer disease.
Complications of pancreatic trauma
Pancreatic fistula, 10%-20%Abscess, 10%-20%PancreatitisPseudocyst, 2%
Types of Pancreatitis
Acute pancreatitis Mild acute pancreatitis (interstitial edema)Severe acute pancreatitis (necrosis, fluid collections)Groove pancreatitis: inflammation localized to groove between duodenum and pancreatic headChronic pancreatitis
Pancreatic necrosis
Diffuse parenchymal (30% area) or focal (>3 cm) nonviable; CT 80-90% accuratePrognosis (necrosis/mortality): 30/8, 50/24, >90/50Infected necrosisRequires surgical debridement, can occur at any time, worse prognosis than pancreatic abscess.HamorrhageLate consequence, erosion into splenic or pancreaticoduodenal arteries or rupture of psuedoaneurysm
Acute fluid collections pancreatitis
40% of pancreatitisNo fibrous capsule, usually within and around pancreatic periphery50% spontaneously resolve, remainder bocome pseudocysts or develop other issue.
Pseudocyst
Encapsulated collection of pancreatic fluid due to microperforation of pancreatic duct (communication seen at ERCP in 50%), must persist at 6 weeks post onset.40% acute pancreatitis, 30% chronic pancreatitis
Pseudocyst prognosis
Prognosis (<5 cm - monitor; otherwise percutaneous drainage; 10% risk superinfection)50% resolve spontaneously20% stable30% other complicationsDissection into adjacent organsHaemorrhage (vessel erosion, thrombosis, pseudoaneurysm)Peritonitis (rupture)Biliary obstructionInfection (abscess) - forms at 2-4 weeks, usually E coli, polymicrobial or candida if immunosuppressed; Percutaneously drained.
Emphysematous pancreatitis
Pancreatitis with superinfection, usually E Coli; high morbidity and mortality but usually resolves with conservative treatment
Chronic pancreatitis Types
Calcifying (alcohol, hyperparathyroisim/hypercalcaemia, hyperlipidaemia, hereditary pancreatitis, juvenile tropical pancreatitis)Obstructive (Trauma, Renal failure, CF, Sclerosing cholangitis, Ampullary tumour, ampullary stenosis)FeaturesFatty replacement, fibrosis, parenchymal calcifications (usually start in head), intraductal calculi.Irregular dilatation pancreatic duct (Grade 1-3)
Complications of chronic pancreatitis
Malabsorption (50%)Pseudocyst (30%)Obstructed CBD (10%)Venous thrombosis (splenic, portal, mesenteric) (5%)Increased risk carcinoma
Autoimmune pancreatitis
Previously idiopathic pancreatitisHistologic diagnosis: dense lymphoplasmacytic infiltrate with scattered eosinophils. May be associated with autoimmune cholangitis. Treatment: steroids.Imaging: diffuse enlargement of pancreas, loss of normal surface indentations, tail retracted from splenic hilum, capsule-like rim enhancement around gland, peripancreatic adenopathy, no calcification, vascular encasement of CBD dilatation
Groove pancreatitis
Involves pancreatic groove (between pancreatic head, duodenum and CBD)Related to PUD, previous gastric resection, duodenal wall cysts, pancreatic heterotopiaBiliary strictures in 50%Imaging: Soft tissue in the pancreaticoduodenal groove with delayed enhancement; small cystic lesions along medial wall of duodenum
Tropical Pancreatitis
Young, no C2H5, usually malnutrition, rapidly progressive, large intraductal calculi (>5 cm), x15-25 increased risk adenoCa
Hereditary Pancreatitis
AD, cationic trypsinogen gene mutation, 50-70x risk pancreatic adenocarcinomaSimilar to tropical pancreatitis on imaging
Heterotopic pancreatic tissue
Duodenum (30%)Stomach (25%) - usually submucosal along greater curveJejunum (15%)Rarely - Meckel’s, ileum, GB, fallopian tubes, umbilicus, oesophagus, spleen, mediastinum, omentum
Pancreatic Ductal Adenocarcinoma
95% pancreatic cancer; Couvosier’s sign (enlarged, nontender GB) in 25%; 8% 1 year survival65% head (5% curable), 35% body and tail (incurable)May be subtle hypodense on NECT, then hypodense on bolus contrast CT; calcifications rare; inverted 3 on barium meal.
Pancreatic AdenoCa unresectability
Criteria for unresectabilitySMA encasedPortal vein or SMV largely encasedMetastases: Liver > LNs > pertioneal/serosal > lung
IPMN / IPMT
From epithelial lining pancreatic duct, secrete mucin, cluster of cysts 1-2 cm diameterPresents with abdominal pain ± pancreatitisCan be side branch (30%; usually in uncinate) or main duct or combined (70%)Associations - AdenoCa (25%), Hyperplasia (25%), Dysplasia (50%)Location: Head/uncinate (55%), Body/tail (10%), Multifocal/diffuse (35%)Increased risk of malignancy:Size > 3 cm or solitary and < 3cmSolid mass or mural noduleMain pancreatic duct > 10 mmIntraluminal calcificationsDiffuse or multifocalHx of DM
Pancreatoblastoma
Usually 1-8 y/o, rareSometimes associated with Beckwith-WiedemannLarge, well-defined, multilobulated with enhancing septa